| |
| |
|
| Insider
Information: |
Mulroy Michael H. |
| Relationship: |
|
| City: |
Anaheim |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
602,177 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$497,853 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
602,177 |
|
|
| Total
Value |
$497,853 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Comarco Inc |
CMRO |
Director |
2013-10-08 |
70,000 |
2011-07-21 |
0 |
Premium* |
|
|
Questcor Pharmaceuticals Inc |
QCOR |
EVP, Strat. Affairs & GC |
2014-08-14 |
0 |
2012-05-23 |
0 |
Premium* |
|
|
Lineage Cell Therapeutics Ord Shs |
LCTX |
Director |
2022-03-24 |
258,555 |
|
0 |
Premium* |
|
|
Asterias Biotherapeutics Inc |
AST |
|
2019-03-01 |
273,622 |
2017-09-25 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
42 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CMRO |
Comarco Inc |
Director |
– • – |
2011-07-21 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
30,000 |
0 |
- |
|
| QCOR |
Questcor Pharmaceuticals ... |
Sr VP, CFO & General Counsel |
• – – |
2012-05-23 |
4 |
B |
$40.00 |
$40,000 |
D/D |
1,000 |
2,117 |
2.74 |
- |
|
| QCOR |
Questcor Pharmaceuticals ... |
Sr VP, CFO & General Counsel |
• – – |
2013-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
52,143 |
54,260 |
0 |
- |
|
| QCOR |
Questcor Pharmaceuticals ... |
Sr VP, CFO & General Counsel |
• – – |
2013-02-24 |
4/A |
A |
$0.00 |
$0 |
D/D |
52,138 |
55,110 |
0 |
- |
|
| QCOR |
Questcor Pharmaceuticals ... |
EVP, CFO & General Counsel |
• – – |
2013-07-31 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
65,782 |
0 |
- |
|
| CMRO |
Comarco Inc |
Director |
• • – |
2013-10-08 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
70,000 |
0 |
- |
|
| QCOR |
Questcor Pharmaceuticals ... |
See Remarks |
• – – |
2014-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
36,000 |
101,782 |
0 |
- |
|
| QCOR |
Questcor Pharmaceuticals ... |
See Remarks |
• – – |
2014-02-24 |
4 |
D |
$0.00 |
$0 |
D/D |
(12,167) |
89,615 |
0 |
- |
|
| QCOR |
Questcor Pharmaceuticals ... |
See Remarks |
• – – |
2014-02-24 |
4 |
D |
$79.46 |
$997,382 |
D/D |
(12,552) |
77,063 |
0 |
- |
|
| QCOR |
Questcor Pharmaceuticals ... |
See Remarks |
• – – |
2014-03-10 |
4 |
S |
$63.91 |
$647,991 |
D/D |
(10,000) |
77,063 |
0 |
- |
|
| QCOR |
Questcor Pharmaceuticals ... |
See Remarks |
• – – |
2014-03-10 |
4 |
OE |
$14.24 |
$142,400 |
D/D |
10,000 |
87,063 |
0 |
- |
|
| QCOR |
Questcor Pharmaceuticals ... |
See Remarks |
• – – |
2014-04-10 |
4 |
OE |
$14.24 |
$142,400 |
D/D |
10,000 |
87,063 |
0 |
- |
|
| QCOR |
Questcor Pharmaceuticals ... |
See Remarks |
• – – |
2014-04-10 |
4 |
S |
$85.03 |
$850,400 |
D/D |
(10,000) |
77,063 |
0 |
- |
|
| QCOR |
Questcor Pharmaceuticals ... |
See Remarks |
• – – |
2014-05-12 |
4 |
OE |
$14.24 |
$142,400 |
D/D |
10,000 |
87,063 |
0 |
- |
|
| QCOR |
Questcor Pharmaceuticals ... |
See Remarks |
• – – |
2014-05-12 |
4 |
S |
$87.97 |
$879,908 |
D/D |
(10,000) |
77,063 |
0 |
- |
|
| QCOR |
Questcor Pharmaceuticals ... |
See Remarks |
• – – |
2014-06-10 |
4 |
S |
$88.57 |
$885,745 |
D/D |
(10,000) |
77,063 |
0 |
- |
|
| QCOR |
Questcor Pharmaceuticals ... |
See Remarks |
• – – |
2014-06-10 |
4 |
OE |
$14.24 |
$142,400 |
D/D |
10,000 |
87,063 |
0 |
- |
|
| QCOR |
Questcor Pharmaceuticals ... |
See Remarks |
• – – |
2014-07-10 |
4 |
OE |
$14.24 |
$142,400 |
D/D |
10,000 |
87,063 |
0 |
- |
|
| QCOR |
Questcor Pharmaceuticals ... |
See Remarks |
• – – |
2014-07-10 |
4 |
S |
$90.86 |
$908,912 |
D/D |
(10,000) |
77,063 |
0 |
- |
|
| QCOR |
Questcor Pharmaceuticals ... |
See Remarks |
• – – |
2014-07-31 |
4 |
D |
$92.35 |
$120,424 |
D/D |
(1,304) |
75,759 |
0 |
- |
|
| QCOR |
Questcor Pharmaceuticals ... |
See Remarks |
• – – |
2014-08-06 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,349 |
75,714 |
0 |
- |
|
| QCOR |
Questcor Pharmaceuticals ... |
See Remarks |
• – – |
2014-08-11 |
4 |
AS |
$92.32 |
$923,348 |
D/D |
(10,000) |
65,714 |
0 |
- |
|
| QCOR |
Questcor Pharmaceuticals ... |
EVP, Strat. Affairs & GC |
• – – |
2014-08-14 |
4 |
D |
$0.00 |
$0 |
D/D |
(73,259) |
0 |
0 |
- |
|
| LCTX |
Lineage Cell Therapeutics... |
Director |
– • – |
2014-10-04 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
32,550 |
|
- |
|
| AST |
Asterias Biotherapeutics ... |
President and CEO |
• • – |
2017-09-25 |
4 |
AB |
$3.25 |
$4,997 |
D/D |
1,537 |
1,537 |
0 |
- |
|
42 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
